British biotechnology company Ingenza has concluded its recent six-month project with Johnson Matthey, a speciality chemicals and sustainable technologies supplier. Together, the companies have developed new, efficient approaches for the production of industrially-relevant enzymes – including cytochrome P450 – through judicious selection of suitable microbial hosts.
IL BIOECONOMISTA 